Listed

Ryder System Inc: Form 10-Q for the period ended Mar 31, 2025

Filed with the SEC on Apr 23, 2025 and accepted by EDGAR at Apr 23, 2025, 11:53 ET.

Share

Management's discussion and analysis

As filed, 1,559 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following table provides information with respect to purchases we made of our common stock during the three months ended March 31, 2025:

(Dollars in millions, except per share)

Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Programs Aggregate Maximum Number of Shares That May Yet Be Purchased Under the Discretionary and Anti-Dilutive Programs (1)
January 1 through January 31, 2025 3,510 $156.21 — 2,984,725
February 1 through February 28, 2025 815,966 164.23 645,644 2,339,081
March 1 through March 31, 2025 410,160 146.71 410,000 1,929,081
Total 1,229,636 $158.37 1,055,644

(1) We currently maintain two share repurchase programs approved by our board of directors in October 2023 and 2024. Refer to Note 10, “Share Repurchase Programs,” in the Notes to Condensed Consolidated Financial Statements for a discussion on our share repurchase programs. Share repurchases under both programs can be made from time to time using our working capital and a variety of methods, including open-market transactions and trading plans established pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934. The timing and actual number of shares repurchased are subject to market conditions, legal requirements and other factors, including balance sheet leverage, availability of quality acquisitions and stock price.

Market risk

As filed, 213 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to Ryder's exposures to market risks since December 31, 2024. Please refer to the 2024 Annual Report on Form 10-K for a complete discussion of Ryder's exposures to market risks.

Controls and procedures

As filed, 1,006 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

As of the end of the first quarter of 2025, we carried out an evaluation, under the supervision and with the participation of management, including Ryder's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of Ryder's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that as of the end of the first quarter of 2025, Ryder's disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) were effective.

Changes in Internal Control over Financial Reporting

During the three months ended March 31, 2025, there were no changes in Ryder's internal control over financial reporting that have materially affected or are reasonably likely to materially affect such internal control over financial reporting.

Risk factors

As filed, 510 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

To our knowledge and except to the extent additional factual information disclosed in this Quarterly Report on Form 10-Q relates to such risk factors, there have been no material changes in the risk factors described in "Item 1A. Risk Factors" in our Form 10-K for the year ended December 31, 2024, filed with the SEC on February 12, 2025. Our operations could also be affected by additional risk factors that are not presently known to us or by factors that we currently consider not material to our business.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-01-01 to 2025-03-31$3.13bnus-gaap:Revenues
Selling, general and administrative3 months2025-01-01 to 2025-03-31$368.0mus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2025-01-01 to 2025-03-31$100.0mus-gaap:InterestExpense
Income tax3 months2025-01-01 to 2025-03-31$36.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-01-01 to 2025-03-31$98.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-01-01 to 2025-03-31$2.27us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-01-01 to 2025-03-31$2.32us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-01-01 to 2025-03-3142,929,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2025-01-01 to 2025-03-31$651.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2025-01-01 to 2025-03-31$514.0mus-gaap:PaymentsToAcquireProductiveAssets
Dividends paid3 months2025-01-01 to 2025-03-31$38.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases3 months2025-01-01 to 2025-03-31$167.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-03-31$151.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-03-31$2.33bnus-gaap:AssetsCurrent
Total assetsAt period end2025-03-31$16.42bnus-gaap:Assets
Current liabilitiesAt period end2025-03-31$3.20bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-03-31$13.42bnus-gaap:Liabilities
Current portion of debtAt period end2025-03-31$1.11bnus-gaap:DebtCurrent
Shareholders' equityAt period end2025-03-31$3.00bnus-gaap:StockholdersEquity
Shares outstandingAt period end2025-03-3141,340,792 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000085961-25-000053. Last ingested by Listed: Nov 14, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.